Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomás Etrych

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 4, 2009
HPMA-based polymer conjugates with drug combinationHana Krakovicová, Tomás Etrych, Karel Ulbrich
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 25, 2005
Polyelectrolyte complex formation and stability when mixing polyanions and polycations in salted media: a model study related to the case of body fluidsTomás Etrych, Laurent Leclercq, Mahfoud Boustta, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 17, 2007
Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapyTomás Etrych, Tomás Mrkvan, Blanka Ríhová, et al.
Pharmaceutical Research|November 19, 2003
Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugsMarkéta Jelínková, Jirí Strohalm, Tomás Etrych, et al.
Molecular Pharmaceutics|June 4, 2010
HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug releaseTomás Etrych, Milada Sírová, L Starovoytova, et al.
Bioconjugate Chemistry|March 22, 2002
Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effectMarek Kovár, Jirí Strohalm, Tomás Etrych, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 7, 2002
HPMA-hydrogels containing cytostatic drugs. Kinetics of the drug release and in vivo efficacyMarek St'astný, Dana Plocová, Tomás Etrych, et al.
Journal of Drug Targeting|November 10, 2006
HPMA based macromolecular therapeutics: internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer compositionOndrej Hovorka, Tomás Etrych, Vladimír Subr, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 7, 2008
Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targetingTomás Etrych, Petr Chytil, Tomás Mrkvan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 28, 2009
HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activityTomás Etrych, Jirí Strohalm, Lubomír Kovár, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 4, 2009
HPMA-based polymer conjugates with drug combinationHana Krakovicová, Tomás Etrych, Karel Ulbrich
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 25, 2005
Polyelectrolyte complex formation and stability when mixing polyanions and polycations in salted media: a model study related to the case of body fluidsTomás Etrych, Laurent Leclercq, Mahfoud Boustta, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 17, 2007
Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapyTomás Etrych, Tomás Mrkvan, Blanka Ríhová, et al.
Pharmaceutical Research|November 19, 2003
Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugsMarkéta Jelínková, Jirí Strohalm, Tomás Etrych, et al.
Molecular Pharmaceutics|June 4, 2010
HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug releaseTomás Etrych, Milada Sírová, L Starovoytova, et al.
Bioconjugate Chemistry|March 22, 2002
Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effectMarek Kovár, Jirí Strohalm, Tomás Etrych, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 7, 2002
HPMA-hydrogels containing cytostatic drugs. Kinetics of the drug release and in vivo efficacyMarek St'astný, Dana Plocová, Tomás Etrych, et al.
Journal of Drug Targeting|November 10, 2006
HPMA based macromolecular therapeutics: internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer compositionOndrej Hovorka, Tomás Etrych, Vladimír Subr, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 7, 2008
Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targetingTomás Etrych, Petr Chytil, Tomás Mrkvan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 28, 2009
HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activityTomás Etrych, Jirí Strohalm, Lubomír Kovár, et al.
Pageof 2